SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001213900-24-023481
Filing Date
2024-03-18
Accepted
2024-03-18 16:05:08
Documents
2
Period of Report
2024-03-12

Document Format Files

Seq Description Document Type Size
1 ownership.html 3  
1 ownership.xml 3 1638
2 POWER OF ATTORNEY ea020201402ex24-1_citius.htm EX-24.1 5786
  Complete submission text file 0001213900-24-023481.txt   9037
Mailing Address 11 COMMERCE DRIVE 1ST FLOOR CRANFORD NJ 07016
Business Address 11 COMMERCE DRIVE 1ST FLOOR CRANFORD NJ 07016 (908) 967-6676
Citius Pharmaceuticals, Inc. (Issuer) CIK: 0001506251 (see all company filings)

IRS No.: 273425913 | State of Incorp.: NV | Fiscal Year End: 0930
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)

Mailing Address 11 COMMERCE DRIVE 1ST FLOOR CRANFORD NJ 07016
Business Address
Smith Robert Joseph (Reporting) CIK: 0002008764 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-38174 | Film No.: 24758974